Duchenne gene therapy from Solid Biosciences produces promising results in early study The company’s shares soared early Tuesday as it released results from three patients

https://www.statnews.com/2025/02/18/solid-duchenne-muscular-dystropthy-gene-therapy-sarepta-elevidys/